Evidence map›Paper›PMID 28060920›Full record

ArticlePLoS pathogens2017

The TIR Homologue Lies near Resistance Genes in Staphylococcus aureus, Coupling Modulation of Virulence and Antimicrobial Susceptibility.

Sabine Patot, Paul Imbert, Jessica Baude, Patricia Martins Simões, Jean-Baptiste Campergue, Arthur Louche, Reindert Nijland, Michèle Bès, Anne Tristan, Frédéric Laurent and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. TLR5 influences the development of type 1 diabetes.BMJ open diabetes research & care · 2025
    Article
  4. Review
  5. Review
  6. Exploring the Accessory Genome of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Characterisation of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. AInternational journal of molecular sciences · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

Sabine PatotCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Paul ImbertLaboratory of Molecular Microbiology and Structural Biochemistry, University of Lyon, CNRS UMR5086, Lyon, France.
Jessica BaudeCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Patricia Martins SimõesCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Jean-Baptiste CampergueCentre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.
Arthur LoucheLaboratory of Molecular Microbiology and Structural Biochemistry, University of Lyon, CNRS UMR5086, Lyon, France.
Reindert NijlandMedical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-0049-3768
Michèle BèsCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Anne TristanCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Frédéric LaurentCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Adrien FischerGenomic Research Laboratory, University of Geneva Hospitals, Geneva, Switzerland.
Jacques SchrenzelGenomic Research Laboratory, University of Geneva Hospitals, Geneva, Switzerland.
François VandeneschCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.ORCID 0000-0001-9412-7106
Suzana SalcedoLaboratory of Molecular Microbiology and Structural Biochemistry, University of Lyon, CNRS UMR5086, Lyon, France.ORCID 0000-0001-5149-7756
Patrice FrançoisGenomic Research Laboratory, University of Geneva Hospitals, Geneva, Switzerland.
Gérard LinaCIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure de Lyon, CNRS UMR 5308, Lyon, France.
Université Claude Bernard Lyon 1 · FRUniversity of Geneva · CHHeidelberg University · DEHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll/interleukin-1 receptor (TIR) domains in Toll-like receptors are essential for initiating and propagating the eukaryotic innate immune signaling cascade. Here, we investigate TirS, a Staphylococcus aureus TIR mimic that is part of a novel bacterial invasion mechanism. Its ectopic expression in eukaryotic cells inhibited TLR signaling, downregulating the NF-kB pathway through inhibition of TLR2, TLR4, TLR5, and TLR9. Skin lesions induced by the S. aureus knockout tirS mutant increased in a mouse model compared with wild-type and restored strains even though the tirS-mutant and wild-type strains did not differ in bacterial load. TirS also was associated with lower neutrophil and macrophage activity, confirming a central role in virulence attenuation through local inflammatory responses. TirS invariably localizes within the staphylococcal chromosomal cassettes (SCC) containing the fusC gene for fusidic acid resistance but not always carrying the mecA gene. Of note, sub-inhibitory concentration of fusidic acid increased tirS expression. Epidemiological studies identified no link between this effector and clinical presentation but showed a selective advantage with a SCCmec element with SCC fusC/tirS. Thus, two key traits determining the success and spread of bacterial infections are linked.

Indexed as

AnimalsBacterial ProteinsCell LineDisease Models, AnimalFusidic AcidHEK293 CellsHumansMacrophagesMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88NeutrophilsPenicillin-Binding ProteinsReceptors, Interleukin-1Bacterial ProteinsFusidic AcidmecA protein, Staphylococcus aureusMembrane GlycoproteinsMyd88 protein, mouseMyeloid Differentiation Factor 88Penicillin-Binding ProteinsReceptors, Interleukin-1TIRAP protein, mouseTirS protein, Staphylococcus aureusToll-Like ReceptorsVirulence Factors

Identifiers

PMID28060920
PMCPMC5218399
OpenAlexW2569139640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.